Seniors' health

1010 WINS Newsroom
December 06, 2019 - 9:10 pm
WASHINGTON (AP) — A bipartisan Senate bill to curb prescription drug costs for Medicare recipients got a makeover Friday to lower copays and make it easier for seniors to budget for their expenses. The updated legislation unveiled by Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore., would lower...
Read More
This image from the Medicare.gov website shows the landing page to find a drug plan for seniors. Leading senators are urging Medicare to allow seniors concerned about their drug plan pick for next year to switch if they believe they received inaccurate information. (Medicare via AP)
1010 WINS Newsroom
December 06, 2019 - 3:43 pm
WASHINGTON (AP) — Leading senators are urging Medicare to allow seniors concerned about their drug plan pick for next year to switch if they received inaccurate information due to changes the agency made this sign-up season. The request from 14 Democrats and one Independent comes as open enrollment...
Read More
In this Nov. 22, 2019, photo, Charles Flagg, who is stricken with Alzheimer's disease, receives the contents of an intravenous bag while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia. (AP Photo/Charles Krupa)
1010 WINS Newsroom
December 05, 2019 - 3:20 pm
SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday but left them sharply divided over whether there’s enough evidence of effectiveness for the medicine to warrant federal approval. Excitement and...
Read More
This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego. (Acadia Pharmaceuticals Inc. via AP)
1010 WINS Newsroom
December 04, 2019 - 8:53 pm
SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...
Read More
FILE - In this file photo dated Monday, Jan. 23, 2017, the president of the All-Russia Athletic Federation, Dmitry Shlyakhtin, speaks to the media in Moscow, Russia. Dmitry Shlyakhtin was suspended Thursday Nov. 21, 2019, on suspicion of obstructing an anti-doping investigation in a blow to Russia’s preparations for the 2020 Olympics. (AP Photo/Pavel Golovkin, FILE)
1010 WINS Newsroom
November 22, 2019 - 2:05 pm
MOSCOW (AP) — The governing body for track and field will consider expelling Russia from membership following new charges that senior officials faked medical records. Russia has been suspended by World Athletics, formerly known as the IAAF, over widespread doping since 2015. There will be a review...
Read More
FILE - In this Nov. 8, 2018 file photo, the U.S. Medicare Handbook is photographed in Washington. Medicare’s new prescription drug plan finder has a glitch that can steer unwitting seniors to coverage that costs much more than they need to pay. (AP Photo/Pablo Martinez Monsivais)
1010 WINS Newsroom
November 21, 2019 - 5:06 pm
WASHINGTON (AP) — Medicare’s revamped prescription plan finder can steer unwitting seniors to coverage that costs much more than they need to pay, according to people who help with sign-ups as well as program experts. Serving some 60 million Medicare recipients, the plan finder is the most commonly...
Read More
1010 WINS Newsroom
November 12, 2019 - 5:40 pm
SAN FRANCISCO (AP) — Billionaire philanthropists Joan and Sandy Weill announced Tuesday they are donating $106 million to launch a research initiative at three West Coast universities aimed at finding treatments for brain disorders like epilepsy and Alzheimer's disease. The donation to the...
Read More
House Speaker Nancy Pelosi of Calif., speaks during a news conference on Capitol Hill in Washington, Thursday, Oct. 31, 2019. (AP Photo/Susan Walsh)
1010 WINS Newsroom
November 05, 2019 - 1:13 pm
WASHINGTON (AP) — The White House has concluded that House Speaker Nancy Pelosi's plan authorizing Medicare to negotiate drug prices is "unworkable" and President Donald Trump will instead support bipartisan legislation in the Senate, a senior White House official said Tuesday. Despite the House...
Read More
Beth Rivera hoses down her property as the Easy fire approaches Wednesday, Oct. 30, 2019, in Simi Valley, Calif. Driven by powerful Santa Ana winds, the brush fire broke out before dawn between the cities of Simi Valley and Moorpark north of Los Angeles and exploded to more than 1,300 acres (526 hectares), threatening 6,500 homes, Ventura County officials said. (AP Photo/Marcio Jose Sanchez)
1010 WINS Newsroom
October 30, 2019 - 10:25 pm
SIMI VALLEY, Calif. (AP) — A wind-whipped outbreak of wildfires outside Los Angeles on Wednesday threatened thousands of homes and horse ranches, forced the smoky evacuation of elderly patients in wheelchairs and narrowly bypassed the Ronald Reagan Presidential Library, protected in part by a...
Read More
FILE - In this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia. The announcement Tuesday, Oct. 22, 2019, is a surprise because the company earlier this year stopped two studies of the drug, called aducanumab, after partial results suggested it was not working. (AP Photo/Matt York, File)
1010 WINS Newsroom
October 22, 2019 - 6:44 pm
Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia. The announcement was a surprise because the drug company earlier this year stopped two...
Read More

Pages